Eosinophilia following radiation therapy.
D003036:Cobalt Isotopes; D004802:Eosinophilia / Q000188:drug therapy / Q000209:etiology*; D004804:Eosinophils / Q000276:immunology; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D005779:Immunodiffusion; D007136:Immunoglobulins / Q000032:analysis; D008175:Lung Neoplasms / Q000532:radiotherapy; D008223:Lymphoma / Q000532:radiotherapy; D008722:Methods; D009369:Neoplasms / Q000532:radiotherapy*; D010051:Ovarian Neoplasms / Q000532:radiotherapy; D010386:Pelvic Neoplasms / Q000532:radiotherapy; D011855:Radiodermatitis / Q000097:blood; D011867:Radioisotope Teletherapy / Q000009:adverse effects*; D013899:Thoracic Neoplasms / Q000532:radiotherapy; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy; D014594:Uterine Neoplasms / Q000532:radiotherapy
D003036:Cobalt Isotopes; D006634:Histamine H1 Antagonists; D007136:Immunoglobulins